← All stocks

BioXcel Therapeutics, Inc.

BTAI Net selling
CIK 0001720893 #4965 in the set updated 17 Sep 2026
Bought (120 mo)
$321.11K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$75.03M
$447.41K on a plan · $12.63M straight out of an exercise
Sold at will
$61.95M
23 of 106 sales
Net
−$74.70M
−$61.63M against sales at will

By person

11 insiders · 149 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Mehta Vimal
CEO and President
$89.34K (21)
$18.86M (30)
−$18.77M
25,484,068
$27.70M
−7.8%
Nandabalan Krishnan
Director
$4.92K (1)
$17.85M (8)
−$17.84M
17,727,750
$19.27M
−4.6%
BioXcel Holdings, Inc. entity
10% owner
$14.59M (1)
−$14.59M
17,566,750
$19.10M
−3.5%
BioXcel LLC entity
10% owner
$14.59M (1)
−$14.59M
8,546,750
$9.29M
−6.9%
O'Neill Vincent
See Remarks
$4.82M (21) scheduled
−$4.82M
19,957
$21.69K
Yocca Frank
Chief Scientific Officer
$66.31K (5)
$3.85M (22)
−$3.79M
26,210
$28.49K
Steinhart Richard I
Chief Financial Officer
$7.60K (3)
$372.18K (10) scheduled
−$364.58K
26,335
$28.63K
MUELLER PETER
Director
$152.94K (12)
+$152.94K
258,320
$280.79K
+9.7%
Rodriguez Javier
See Remarks
$81.81K (9) scheduled
−$81.81K
26,838
$29.17K
Wiley Matthew T.
See Remarks
$6.56K (4) scheduled
−$6.56K
19,011
$20.66K
+1,801%
MACK DAVID J.
Director
20,317
$22.08K

No percentages here. This company's share count has moved by a factor of 7.8 over the window, from 5,486,038 to 42,748,364 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Mehta Vimal
20 May 2026
CEO and President
Sold on a plan
19,419
$1.09
$21.11K
Steinhart Richard I
20 May 2026
Chief Financial Officer
Sold on a plan
6,845
$1.09
$7.43K
Rodriguez Javier
20 May 2026
See Remarks
Sold on a plan
6,560
$1.08
$7.11K
Yocca Frank
20 May 2026
Chief Scientific Officer
Sold on a plan
6,845
$1.09
$7.43K
Yocca Frank
16 Dec 2024
Chief Scientific Officer
Sold on a plan
225
$0.35
$79.02
Yocca Frank
16 Dec 2024
Chief Scientific Officer
Sold on a plan
205
$0.36
$72.80
Rodriguez Javier
16 Dec 2024
See Remarks
Sold on a plan
220
$0.36
$78.47
Rodriguez Javier
16 Dec 2024
See Remarks
Sold on a plan
210
$0.36
$74.55
Steinhart Richard I
16 Dec 2024
Chief Financial Officer
Sold on a plan
372
$0.36
$133.18
Steinhart Richard I
16 Dec 2024
Chief Financial Officer
Sold on a plan
205
$0.36
$73.80
Mehta Vimal
16 Dec 2024
CEO and President
Sold on a plan
2,134
$0.36
$773.36
Mehta Vimal
16 Dec 2024
CEO and President
Sold on a plan
983
$0.36
$357.91
O'Neill Vincent
16 Dec 2024
See Remarks
Sold on a plan
165
$0.35
$58.13
O'Neill Vincent
3 Oct 2024
See Remarks
Sold on a plan
5,556
$0.55
$3.06K
Steinhart Richard I
3 Oct 2024
Chief Financial Officer
Sold on a plan
7,175
$0.55
$3.95K
Yocca Frank
3 Oct 2024
Chief Scientific Officer
Sold on a plan
7,175
$0.55
$3.95K
Rodriguez Javier
3 Oct 2024
See Remarks
Sold on a plan
6,863
$0.55
$3.77K
Wiley Matthew T.
3 Oct 2024
Chief Commercial Officer
Sold on a plan
6,272
$0.55
$3.45K
Wiley Matthew T.
16 Sep 2024
Chief Commercial Officer
Sold on a plan
215
$0.69
$148.52
O'Neill Vincent
16 Sep 2024
See Remarks
Sold on a plan
138
$0.69
$95.33
Rodriguez Javier
16 Sep 2024
See Remarks
Sold on a plan
345
$0.69
$238.05
Steinhart Richard I
16 Sep 2024
Chief Financial Officer
Sold on a plan
356
$0.69
$245.60
Mehta Vimal
16 Sep 2024
CEO and President
Sold on a plan
1,150
$0.69
$794.08
Mehta Vimal
16 Sep 2024
CEO and President
Sold on a plan
832
$0.69
$572.83
Yocca Frank
16 Sep 2024
Chief Scientific Officer
Sold on a plan
355
$0.69
$244.70
Mehta Vimal
17 Jun 2024
CEO and President
Sold on a plan
2,134
$1.28
$2.74K
O'Neill Vincent
17 Jun 2024
See Remarks
Sold on a plan
155
$1.29
$199.18
Rodriguez Javier
17 Jun 2024
See Remarks
Sold on a plan
361
$1.26
$456.02
Steinhart Richard I
17 Jun 2024
Chief Financial Officer
Sold on a plan
372
$1.26
$469.54
Wiley Matthew T.
17 Jun 2024
Chief Commercial Officer
Sold on a plan
244
$1.26
$308.10
Yocca Frank
17 Jun 2024
Chief Scientific Officer
Sold on a plan
372
$1.28
$476.16
Mehta Vimal
5 Jun 2024
CEO and President
Sell indirect
126,014
$1.58
$199.62K
Mehta Vimal
5 Jun 2024
CEO and President
Sell indirect
283,122
no price
Mehta Vimal
4 Jun 2024
CEO and President
Sell indirect
126,014
$1.63
$205.52K
Mehta Vimal
4 Jun 2024
CEO and President
Sell indirect
283,123
no price
Mehta Vimal
4 Jun 2024
CEO and President
Sell indirect
609,221
no price
Yocca Frank
4 Apr 2024
Chief Scientific Officer
Sold on a plan
1,067
$2.64
$2.81K
Rodriguez Javier
4 Apr 2024
See Remarks
Sold on a plan
1,012
$2.64
$2.67K
Wiley Matthew T.
4 Apr 2024
CHIEF COMMERCIAL OFFICER
Sold on a plan
1,008
$2.64
$2.66K
Steinhart Richard I
4 Apr 2024
Chief Financial Officer
Sold on a plan
1,069
$2.64
$2.82K
Mehta Vimal
4 Apr 2024
CEO and President
Sold on a plan
4,439
$2.62
$11.65K
Mehta Vimal
4 Apr 2024
CEO and President
Sold on a plan
829
$2.62
$2.17K
O'Neill Vincent
4 Apr 2024
See Remarks
Sold on a plan
165
$2.62
$432.48
Mehta Vimal
16 Jun 2023
CEO and President
Sold after exercise
747
$21.89
$16.35K
Mehta Vimal
16 Jun 2023
CEO and President
Sold after exercise
4,266
$20.90
$89.16K
Mehta Vimal
16 Jun 2023
CEO and President
Sold after exercise
24,987
$20.01
$499.99K
Mehta Vimal
15 Jun 2023
CEO and President
Sold after exercise
8,012
$21.90
$175.46K
Mehta Vimal
15 Jun 2023
CEO and President
Sold after exercise
21,988
$21.41
$470.76K
Mehta Vimal
22 May 2023
CEO and President
Sold on a plan
6,500
$25.79
$167.64K
Rodriguez Javier
15 May 2023
See Remarks
Sold on a plan
1,785
$27.32
$48.76K
Steinhart Richard I
15 May 2023
Chief Financial Officer
Sold on a plan
5,000
$27.17
$135.86K
Nandabalan Krishnan
6 Apr 2023
Director
Sold after exercise
60,000
$17.32
$1.04M
Mehta Vimal
21 Mar 2023
CEO and President
Sold after exercise
900
$20.15
$18.14K
Mehta Vimal
21 Mar 2023
CEO and President
Sold after exercise
29,100
$19.70
$573.27K
Mehta Vimal
20 Mar 2023
CEO and President
Sold after exercise
604
$18.88
$11.40K
Mehta Vimal
20 Mar 2023
CEO and President
Sold after exercise
3,896
$18.22
$70.99K
Mehta Vimal
20 Mar 2023
CEO and President
Sold after exercise
5,333
$18.86
$100.58K
Mehta Vimal
20 Mar 2023
CEO and President
Sold after exercise
24,667
$18.20
$448.94K
Rodriguez Javier
15 Mar 2023
See Remarks
Sell
950
$19.63
$18.64K
O'Neill Vincent
15 Mar 2023
Chief Medical Officer
Sell
845
$19.70
$16.64K
Yocca Frank
15 Mar 2023
Chief Scientific Officer
Sell
985
$19.69
$19.40K
Steinhart Richard I
15 Mar 2023
Chief Financial Officer
Sell
2,084
$19.50
$40.64K
O'Neill Vincent
20 Jan 2023
Chief Medical Officer
Sold after exercise
29,713
$30.00
$891.39K
Yocca Frank
20 Jan 2023
Chief Scientific Officer
Sell
50,000
$30.00
$1.50M
Nandabalan Krishnan
5 Jan 2023
Director
Sold after exercise
800
$22.93
$18.34K
Nandabalan Krishnan
5 Jan 2023
Director
Sold after exercise
25,089
$22.32
$559.99K
Nandabalan Krishnan
4 Jan 2023
Director
Sold after exercise
9,821
$22.21
$218.12K
Nandabalan Krishnan
4 Jan 2023
Director
Sold after exercise
24,290
$21.59
$524.42K
Mehta Vimal
16 Dec 2022
CEO and President
Sold after exercise
9,887
$19.92
$196.95K
Mehta Vimal
16 Dec 2022
CEO and President
Sold after exercise
20,113
$19.21
$386.37K
Mehta Vimal
15 Dec 2022
CEO and President
Sold after exercise
7,206
$20.19
$145.49K
Mehta Vimal
15 Dec 2022
CEO and President
Sold after exercise
22,794
$19.86
$452.69K
Nandabalan Krishnan
11 Nov 2022
Director
Sold after exercise
32,550
$15.00
$488.25K
Nandabalan Krishnan
10 Nov 2022
Director
Sold after exercise
27,450
$15.00
$411.75K
BioXcel Holdings, Inc.
25 Jun 2021
10% owner
Sell indirect
473,250
$30.83
$14.59M
BioXcel LLC
25 Jun 2021
10% owner
Sell
473,250
$30.83
$14.59M
Nandabalan Krishnan
25 Jun 2021
Director
Sell indirect
473,250
$30.83
$14.59M
Mehta Vimal
25 Jun 2021
CEO, President and Secretary
Sell indirect
473,250
$30.83
$14.59M
Yocca Frank
15 Mar 2021
Chief Scientific Officer
Sell
630
$49.30
$31.06K
Yocca Frank
15 Mar 2021
Chief Scientific Officer
Sell
14,370
$48.47
$696.51K
O'Neill Vincent
17 Feb 2021
Chief Medical Officer
Sold after exercise
600
$57.17
$34.30K
O'Neill Vincent
17 Feb 2021
Chief Medical Officer
Sold after exercise
9,573
$56.60
$541.83K
O'Neill Vincent
17 Feb 2021
Chief Medical Officer
Sold after exercise
6,872
$55.55
$381.74K
O'Neill Vincent
17 Feb 2021
Chief Medical Officer
Sold after exercise
5,655
$54.45
$307.91K
O'Neill Vincent
17 Feb 2021
Chief Medical Officer
Sold after exercise
2,300
$53.77
$123.67K
Yocca Frank
16 Feb 2021
Chief Scientific Officer
Sell
600
$61.20
$36.72K
Yocca Frank
16 Feb 2021
Chief Scientific Officer
Sell
1,772
$60.43
$107.08K
Yocca Frank
16 Feb 2021
Chief Scientific Officer
Sell
500
$59.46
$29.73K
Yocca Frank
16 Feb 2021
Chief Scientific Officer
Sell
2,886
$58.54
$168.95K
Yocca Frank
16 Feb 2021
Chief Scientific Officer
Sell
1,137
$57.71
$65.62K
Yocca Frank
16 Feb 2021
Chief Scientific Officer
Sell
6,805
$56.49
$384.41K
Yocca Frank
16 Feb 2021
Chief Scientific Officer
Sell
1,300
$55.88
$72.64K
Steinhart Richard I
1 Feb 2021
Chief Financial Officer
Sold after exercise
3,750
$48.15
$180.56K
Yocca Frank
25 Jan 2021
Chief Scientific Officer
Sold after exercise
4,107
$49.35
$202.68K
Yocca Frank
25 Jan 2021
Chief Scientific Officer
Sold after exercise
6,521
$48.39
$315.55K
Yocca Frank
25 Jan 2021
Chief Scientific Officer
Sold after exercise
3,472
$47.62
$165.34K
Yocca Frank
25 Jan 2021
Chief Scientific Officer
Sold after exercise
900
$46.94
$42.25K
O'Neill Vincent
19 Jan 2021
Chief Medical Officer
Sold after exercise
1,377
$52.45
$72.22K
O'Neill Vincent
19 Jan 2021
Chief Medical Officer
Sold after exercise
1,500
$51.45
$77.18K
O'Neill Vincent
19 Jan 2021
Chief Medical Officer
Sold after exercise
2,700
$50.38
$136.03K
O'Neill Vincent
19 Jan 2021
Chief Medical Officer
Sold after exercise
12,665
$49.27
$624.00K
O'Neill Vincent
19 Jan 2021
Chief Medical Officer
Sold after exercise
6,758
$48.43
$327.29K
O'Neill Vincent
28 Dec 2020
Chief Medical Officer
Sold after exercise
1,353
$53.54
$72.44K
O'Neill Vincent
28 Dec 2020
Chief Medical Officer
Sold after exercise
3,951
$52.68
$208.14K
O'Neill Vincent
28 Dec 2020
Chief Medical Officer
Sold after exercise
5,727
$51.75
$296.37K
O'Neill Vincent
28 Dec 2020
Chief Medical Officer
Sold after exercise
13,969
$50.77
$709.21K
Yocca Frank
14 Feb 2020
Chief Scientific Officer
Exercised, kept
80,000
$0.41
$32.80K
MUELLER PETER
23 Aug 2019
Director
Buy
1,554
$9.34
$14.51K
MUELLER PETER
22 Aug 2019
Director
Buy
6,646
$8.83
$58.68K
MUELLER PETER
21 Aug 2019
Director
Buy
1,800
$8.42
$15.16K
Mehta Vimal
16 Aug 2019
CEO, President and Secretary
Buy
974
$8.89
$8.66K
Mehta Vimal
15 Aug 2019
CEO, President & Secretary
Buy
2,625
$8.67
$22.76K
Mehta Vimal
14 Aug 2019
CEO, President & Secretary
Buy
358
$8.44
$3.02K
Yocca Frank
13 Aug 2019
Chief Scientific Officer
Buy
6,547
$8.67
$56.76K
Mehta Vimal
13 Aug 2019
CEO, President & Secretary
Buy
1,000
$8.75
$8.75K
Mehta Vimal
14 Dec 2018
CEO, President, Secretary
Buy
100
$4.50
$450.00
Mehta Vimal
14 Dec 2018
CEO, President, Secretary
Buy
400
$4.49
$1.80K
Mehta Vimal
14 Dec 2018
CEO, President, Secretary
Buy
500
$4.48
$2.24K
Mehta Vimal
14 Dec 2018
CEO, President, Secretary
Buy
200
$4.32
$864.00
Mehta Vimal
14 Dec 2018
CEO, President, Secretary
Buy
800
$4.27
$3.42K
MUELLER PETER
7 Dec 2018
Director
Buy
6,905
$5.01
$34.59K
MUELLER PETER
7 Dec 2018
Director
Buy
495
$5.00
$2.48K
MUELLER PETER
6 Dec 2018
Director
Buy
100
$5.01
$501.00
MUELLER PETER
6 Dec 2018
Director
Buy
1,295
$5.00
$6.48K
Mehta Vimal
4 Dec 2018
CEO, President, Secretary
Buy
500
$5.15
$2.58K
Mehta Vimal
4 Dec 2018
CEO, President, Secretary
Buy
500
$5.09
$2.55K
Yocca Frank
4 Dec 2018
Chief Scientific Officer
Buy
450
$5.20
$2.34K
MUELLER PETER
4 Dec 2018
Director
Buy
2,062
$5.15
$10.62K
MUELLER PETER
4 Dec 2018
Director
Buy
200
$5.13
$1.03K
MUELLER PETER
4 Dec 2018
Director
Buy
344
$5.12
$1.76K
MUELLER PETER
4 Dec 2018
Director
Buy
325
$5.11
$1.66K
MUELLER PETER
4 Dec 2018
Director
Buy
1,076
$5.09
$5.48K
Steinhart Richard I
3 Dec 2018
Chief Financial Officer
Buy
500
$5.20
$2.60K
Mehta Vimal
3 Dec 2018
CEO, President, Secretary
Buy
500
$5.20
$2.60K
Mehta Vimal
3 Dec 2018
CEO, President, Secretary
Buy
100
$5.18
$518.00
Mehta Vimal
3 Dec 2018
CEO, President, Secretary
Buy
100
$5.14
$514.00
Mehta Vimal
3 Dec 2018
CEO, President, Secretary
Buy
100
$5.13
$513.00
Mehta Vimal
3 Dec 2018
CEO, President, Secretary
Buy
200
$5.10
$1.02K
Yocca Frank
3 Dec 2018
Chief Scientific Officer
Buy
450
$5.23
$2.35K
Mehta Vimal
30 Nov 2018
CEO, President, Secretary
Buy
300
$5.20
$1.56K
Mehta Vimal
30 Nov 2018
CEO, President, Secretary
Buy
100
$5.17
$517.00
Mehta Vimal
30 Nov 2018
CEO, President, Secretary
Buy
300
$5.05
$1.52K
Mehta Vimal
30 Nov 2018
CEO, President, Secretary
Buy
300
$5.04
$1.51K
Yocca Frank
30 Nov 2018
Chief Scientific Officer
Buy
450
$5.20
$2.34K
Steinhart Richard I
30 Nov 2018
Chief Financial Officer
Buy
500
$5.00
$2.50K
Steinhart Richard I
29 Nov 2018
Chief Financial Officer
Buy
500
$5.00
$2.50K
Yocca Frank
29 Nov 2018
Chief Scientific Officer
Buy
500
$5.02
$2.51K
Nandabalan Krishnan
29 Nov 2018
Director
Buy
1,000
$4.92
$4.92K
Mehta Vimal
12 Mar 2018
CEO, President and Secretary
Buy indirect
2,000
$11.00
$22.00K

What was left out

Form 4 filings counted 230
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 41
Sales straight out of an exercise 42
Sales at will 23
Transactions with no price 3
Shares from compensation/vesting 2,968,409
Sales filed before the plan box existed 18
History held since 13 Mar 2018